Deutsche Bank
ELOX

Deutsche Bank’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Deutsche Bank’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,700
Closed -$135K – 4760
2021
Q2 		$135K Buy
1,700
+1,252
+279% +$104K ﹤0.01% 4009
2021
Q1 		$59K Sell
448
-40
-8% -$6.11K ﹤0.01% 4194
2020
Q4 		$77K Buy
488
+121
+33% +$14.8K ﹤0.01% 3987
2020
Q3 		$39K Buy
367
+33
+10% +$3.95K ﹤0.01% 3983
2020
Q2 		$40K Buy
334
+122
+58% +$13.8K ﹤0.01% 3913
2020
Q1 		$16K Sell
212
-13
-6% -$2.12K ﹤0.01% 3974
2019
Q4 		$65K Buy
225
+50
+29% +$10.1K ﹤0.01% 3827
2019
Q3 		$30K Sell
175
-227
-56% -$64.6K ﹤0.01% 4176
2019
Q2 		$158K Sell
402
-248
-38% -$104K ﹤0.01% 3964
2019
Q1 		$303K Buy
650
+1
+0.2% +$486 ﹤0.01% 3754
2018
Q4 		$311K Sell
649
-628
-49% -$347K ﹤0.01% 3618
2018
Q3 		$869K Buy
1,277
+243
+24% +$156K ﹤0.01% 3438
2018
Q2 		$706K Buy
+1,034
New +$670K ﹤0.01% 3645

Other funds holding ELOX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Deutsche Bank's ELOX Position: Q3 2021 in Review

Deutsche Bank sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q3 2021, closing a stake of 1,700 shares — an estimated $135K sold.

Deutsche Bank first reported a position in ELOX in Q2 2018 and held it in 13 quarters. The position peaked at $869K in Q3 2018. 40 funds tracked by Wall St. Rank hold ELOX as of Q3 2021.

  • Deutsche Bank reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Deutsche Bank sold 1,700 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q3 2021, an estimated $135K.
  • Deutsche Bank first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 13 quarters.
  • Deutsche Bank's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $869K in Q3 2018.
  • 40 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q3 2021.

Based on Deutsche Bank's 13F filing for Q3 2021, filed 4 Nov 2021.